RESUMO
Development and use of a drug-use evaluation (DUE) program for hospital and outpatient facilities of a health-maintenance organization (HMO) are described. A full-time pharmacist coordinates the DUE program. Primary components of the DUE program are (1) establishment and use of drug therapy management protocols, (2) periodic review and evaluation of drug-use statistics by the pharmacy and therapeutics (P&T) committee, (3) monitoring of pharmacist interventions, and (4) evaluation of specific drug use within individual medical staff departments. Information from all DUE activities is channeled through the P&T committee and linked to the HMO's overall quality assurance program. The DUE program has the support of the HMO physicians. It has enhanced the quality of drug use and identified opportunities to further improve the quality of patient care. In surveys by the Joint Commission on Accreditation of Healthcare Organizations, the HMO facilities have received no recommendations. Pharmacists and physicians have cooperated to develop a comprehensive DUE program for an HMO.
Assuntos
Tratamento Farmacológico/normas , Sistemas Pré-Pagos de Saúde/normas , Serviço de Farmácia Hospitalar/normas , Garantia da Qualidade dos Cuidados de Saúde/organização & administração , California , Protocolos Clínicos , Uso de Medicamentos/estatística & dados numéricos , Hospitais com 100 a 299 Leitos , Humanos , Joint Commission on Accreditation of Healthcare Organizations , Equipe de Assistência ao Paciente , Comitê de Farmácia e Terapêutica , Avaliação de Programas e Projetos de Saúde , Projetos de PesquisaRESUMO
The antenatal sonographic appearance of gastroschisis is described. The findings consist of numerous extra-abdominal "cystic masses" respresenting loops of fluid-filled bowel eviscerated through the abdominal defect. This patient also had associated polyhydramnios, possibly on the basis of a functional bowel abnormality.
